Prognostic Implications of Claudin 4 and Rock 1 in Triple Negative Breast Cancer

Journal of Cancer Treatment and Research
doi 10.11648/j.jctr.20170506.13
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Science Publishing Group

Related search

Exploring Specific Prognostic Biomarkers in Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Neutrophil:Lymphocyte Ratios Have Prognostic Value in Triple-Negative Breast Cancer

Journal of Nihon University Medical Association
2017English

Identification of New Prognostic Biomarkers for Triple Negative Breast Cancer

English

TLR5: A Prognostic and Monitoring Indicator for Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Triple-Negative Breast Cancer

2018English

Prognostic Role of Family History in Patients With Triple Negative Breast Cancer

Turk Onkoloji Dergisi
Oncology
2020English

Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer

Frontiers in Medicine
Medicine
2019English

Nottingham Prognostic Index Is an Applicable Prognostic Tool in Non-Metastatic Triple-Negative Breast Cancer

Asian Pacific Journal of Cancer Prevention
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy